𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1–43 Activity and Safety of the Antiestrogen EM-800, the Orally Active Precursor of Acolbifene, in Tamoxifen-Resistant Breast Cancer

✍ Scribed by Elledge, R.M.

Book ID
122025794
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
89 KB
Volume
16
Category
Article
ISSN
1043-321X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term inhibitory effect of the orall
Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice
✍ Steeve Couillard; Claude Labrie; Sylvain Gauthier; Yves Merand; Shankar Mohan Si 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 174 KB 👁 2 views

The antiproliferative effect of the new antiestrogen EM-800 has been studied during 40 weeks of treatment on human breast carcinoma ZR-75-1 xenografts in ovariectomized nude mice supplemented with estrone (0.5 g, s.c. daily). At the daily 50 g (approximately 2.5 mg/kg) oral dose, EM-800 caused a com

Characterization of the effects of the n
Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro
✍ Jacques Simard; Claude Labrie; Alain Bélanger; Sylvain Gauthier; Shankar M. Sing 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 256 KB 👁 2 views

Since estrogens play a predominant role in the development and growth of human breast cancer, antiestrogens represent a logical approach to the treatment of this disease. The present study compares the effects of the novel nonsteroidal anti-estrogen EM-800 and related compounds with those of a serie